The activity of amphotericin B methyl ester was compared with that of amphotericin B, using Candida albicans (34 isolates), Torulopsis glabrata (12 isolates), Filobasidiella neoformans (stat. conid. Cryptococcus neoformans) (14 isolates), and Coccidioides immitis (37 isolates) and tube dilution in a totally synthetic, completely defined medium (SAAMF) with inocula of 104 colonyforming units per ml. Minimal inhibitory concentrations were read after 24 h at 34°C for C. albicans and T. glabrata, and after 48 h at 340C for C. immitis and F. neoformans. Minimal lethal concentrations were determined by subculture of 10% of the volume of the cultures without evident growth onto Sabouraud glucose agar medium. Overall, amphotericin B methyl ester was slightly less active than amphotericin B, with the differences attaining statistical significance for: (i) inhibition of C. albicans and T. glabrata and (ii) killing of T. glabrata.
Primarily because of adverse effects and limited distribution in the body, amphotericin B (AMB) is less than the ideal antifungal antimicrobial agent for systemic therapy (11) . Semisynthesis of the methyl ester of AMB (AME) (20) resulted in a compound which is less toxic (15, 16) and more generally distributed, e.g., enters the urine (14) .
A limited number of a variety of stock culture strains of fungi were tested in vitro for susceptibility to AMB and AME by Howarth et al. in 1975 (13) . They reported the antifungal activity of AME to be slightly lower than that of AMB.
In our earlier report of testing the susceptibility of clinical isolates of fungi in vitro [P. D. Hoeprich Procedure. Cultures of C. albicans and T. glabrata were grown overnight at 34°C in a totally synthetic, completely defined, liquid culture medium, SAAMF (12) , yielding 107 and 108 colony-forming units per ml, respectively. Dilutions were made in SAAMF to a concentration of 104 colony-forming units per ml; 0.9 ml of this suspension was added to each drug and control tube. 905
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The isolates of F. neoformans were grown for 48 h at 34°C in SAAMF, resulting in 106 colony-forming units per ml. These cultures were then diluted and distributed exactly as the previous two yeasts.
Coccidioidal arthroconidia (formerly called arthrospores) were harvested from the surface of agar slants of each isolate by gently washing with sterile 0.9% (wt/vol) NaCl solution. On the basis of direct counts in a hemocytometer (after dilution in Gram iodine solution), the suspensions were diluted in SAAMF to 10' colony-forming units per ml and distributed in the same manner as the yeasts. After mechanical mixing (Vortex mixer, Lab-Line Instruments, Inc., Melrose Park, Ill.), each set of tubes was incubated at 34°C for 24 h (C. albicans and T. glabrata) or for 48 h (F. neoformans and C. immitis).
x 4 The lowest concentration of antimicrobial agent which .4 prevented visible growth was recorded as the MIC. Minimal lethal concentrations (MLCs) were determined by spreading 10% of the volume of each tube with no visible growth over one-half the surface of 20 ml of Sabouraud glucose agar medium contained in a 100-mm-diameter petri plate. After incubation at 34°C for 24 h (C. albicans and T. glabrata) or 2 to 7 days, depending on the growth of subcultures from the control tubes (F. neoformans and C. immitis), the lowest concentration which yielded fewer than 5 colonies per 0.1 ml (>99.5% loss of viability) was accepted as the MLC.
RESULTS
The ranges of the MICs and the geometric mean MICs are listed in Table 1 . When the geometric mean MICs of AMB and AME were compared by using the independent t test, the means were significantly lower for AMB with C. albicans and T. glabrata (P < 0.05). With F. neoformans and C. immitis, however, there were _ no statistically significant differences, although the MICs were usually lower with AMB than with AME. The cumulative MICs, plotted in Fig. 1, portray 24 with AME), putative geometric means were calculated by taking the next higher doubling dilution as the MLC (i.e., 38.4 jig for AMB and 39.0 ,ug for AME). When the geometric mean MLCs of AMB and AME were compared by using the independent t test, the means were significantly different only with T. glabrata (P < 0.05). Again the MLCs were usually lower for AMB than for AME, as is reflected in the cumulative plot (Fig. 2) .
DISCUSSION
In contrast to the paucity of comparisons of the susceptibility of fungi to AME and AMB by (1, 4, 5, 7, 8-10, 12, 18, 19, 23, 24) . It is difficult to relate the MICs of these reports to the present work because different strains of fungi were tested in each study. Other factors are also of importance, as can be illustrated by considering the different MICs reported for just four of the strains of C. immitis examined by us in 1975 (12) when tested in another laboratory in 1977 (4). In our work, the range in MICs for these four strains was 0.48 to 24.01 ,ug/ml, whereas Collins and Pappagianis reported a range of 0.078 to 0.16 ,ug/ml. Such differences are reasonably related to differences in inocula (preparation and density in the test systems), culture media (constitution and physical state), AMB "solutions" (menstruums and dilution schemes), and conditions of incubation (temperature and duration).
Apparently, with clinical isolates as with stock strains of fungi (13), AME is slightly less active in vitro than the parent AMB. It is possible that AME is simply less active than AMB. On a molecular level, this would mean that AME had less affinity for ergosterol than AMB. However, when polyene and corresponding polyene ester pairs were examined in vitro, it was found that AME bound to ergosterol more tightly and more completely than AMB (3, 6) .
The molecular, or near molecular, dispersion of AME (22) may render it more susceptible to spontaneous degradation than AMB. Relative to AME, the molecules of AMB are sheltered, protected by aggregation into colloidal particles.
Possibly also, AMB wiU wreak greater damage than AME at the sterol receptor sites on the fungal cell membrane (17, 21 an equimolar quantity of AME would provide many more reactive particles.
In a practical sense, the differences in the MICs and MLCs of AMB and AME by in vitro testing are probably of little consequence. The decreased toxicity of AME is of much greater clinical significance. The fact that doses of AME can be given safely that are five times higher than the maximal tolerable doses of AMB further diminishes the importance of slightly higher MICs for AME. The usual maximal dose of AMB is 1 mg/kg of body weight and yields peak serum concentrations of 1.5 to 3.0 ,tg/ml. With AME, doses of 5 mg/kg of body weight are well tolerated by both nonhuman primates and humans and produce peak serum concentrations of 15 to 30 ,ug/ml. During the 48 h after such doses, the concentrations of AME in the serum always exceed those of AMB (11, 14 Fig. 1 and 2 ) and the concentrations attainable in the serum with well-tolerated doses of AME, we doubt that the small differences in susceptibility demonstrated in vitro are of clinical significance. 
